glp-1 drugs and dementia Can blockbuster weight loss also protect brain health? MIND Matters | Quarterly Newsletter

doi:10.1016/j.amjmed.2023.07.016 176

Leveraging advanced technology, orders are tracked from the moment of submission, alerting the recipient via text or email throughout each step of the process so you or your patients always know what to expect

An important regulatory note: On December 22, 2025, the FDA approved Novo Nordisk's Wegovy tablet (oral semaglutide 25 mg) as the first oral GLP-1 receptor agonist for chronic weight management, with a national launch in January 2026

This kind of sweating could mean there's something else going on in your body

Arabidopsis transcription factors SPL1 and SPL12 confer plant thermotolerance at reproductive stage

L-CARNITINE also assists in the oxidation of pyruvate and branched chain amino acids in the energy cycle, and prevents the buildup of fatty complexes within cells which can damage muscle cell membranes